Latest News about RGEN
Recent news which mentions RGEN
   Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
   
  October 28, 2021
  Tickers 
   RGEN
  
  
  From Motley Fool
 From Benzinga
 
   Earnings Scheduled For October 28, 2021
   
  
  
  October 28, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 
   NIO Stock Is Very Richly Valued, But I Can See Why It Tempts People
   
  
  
  October 19, 2021
  From InvestorPlace
 
   2 Tricks and a Treat for Gene Therapy Investors
   
  
  
  October 18, 2021
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
   
  
  
  October 14, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
   
  
  
  September 30, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
   
  
  
  September 23, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
   
  
  
  September 22, 2021
  From Benzinga
 
   3 Unstoppable Healthcare Stocks to Buy With Just $1,000
   
  
  
  September 22, 2021
  From Motley Fool
 
   Great Performers That Are Still Great Stocks
   
  
  
  September 21, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
   
  
  
  September 21, 2021
  From Benzinga
 
   10 Biggest Price Target Changes For Friday
   
  
  
  September 17, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
   
  
  
  September 17, 2021
  From Benzinga
 
   Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal
   
  September 16, 2021
  Tickers 
   RGEN
  
  
  From Benzinga
 From Benzinga
 
   Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock
   
  September 14, 2021
  Tickers 
   RGEN
  
  
  From Benzinga
 
   The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
   
  
  
  September 08, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
   
  
  
  September 03, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
   
  
  
  September 02, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
   
  
  
  September 01, 2021
  From Benzinga
 From Benzinga
 
   Stocks That Hit 52-Week Highs On Friday
   
  
  
  August 27, 2021
  From Benzinga
 
   The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
   
  
  
  August 27, 2021
  From Benzinga
 From Benzinga
 
   Stocks That Hit 52-Week Highs On Wednesday
   
  
  
  August 25, 2021
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.